Sirtris Pharmaceuticals
Sirtris Pharmaceuticals develops small molecule drugs for the treatment of aging and metabolic diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€655m (Public information from Apr 2008)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $5.0m | Seed | |
$13.0m | Series A | ||
$27.0m | Series B | ||
$37.0m | Series C | ||
| N/A | N/A | IPO | |
$720m Valuation: $720m | Acquisition | ||
| Total Funding | €74.5m | ||